Genotype-phenotype relationship in 2 SMA III patients with novel mutations in the Tudor domain
暂无分享,去创建一个
V. Meininger | F. Salachas | T. Maisonobe | B. Gérard | P. Pradat | S. Drunat | M. Fraidakis | P. Pradat | M.J. Fraidakis
[1] L. Vallée,et al. Insights into genotype–phenotype correlations in spinal muscular atrophy: A retrospective study of 103 patients , 2011, Muscle & nerve.
[2] R. Touraine,et al. A rare SMN2 variant in a previously unrecognized composite splicing regulatory element induces exon 7 inclusion and reduces the clinical severity of spinal muscular atrophy , 2010, Human mutation.
[3] J. Mendell,et al. An analysis of disease severity based on SMN2 copy number in adults with spinal muscular atrophy , 2009, Muscle & nerve.
[4] Y. Hua,et al. A positive modifier of spinal muscular atrophy in the SMN2 gene. , 2009, American journal of human genetics.
[5] T. Crawford,et al. A SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA mice. , 2009, Human molecular genetics.
[6] W. Nyka,et al. Unaffected patients with a homozygous absence of the SMN1 gene , 2008, European Journal of Human Genetics.
[7] B. Engelen,et al. A natural history study of late onset spinal muscular atrophy types 3b and 4 , 2008, Journal of Neurology.
[8] E. Kmiec,et al. Genetic conversion of an SMN2 gene to SMN1: a novel approach to the treatment of spinal muscular atrophy. , 2008, Experimental cell research.
[9] J. Manley,et al. hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing. , 2007, Human molecular genetics.
[10] T. Prior. Spinal Muscular Atrophy Diagnostics , 2007, Journal of child neurology.
[11] E. Zapletalová,et al. Analysis of point mutations in the SMN1 gene in SMA patients bearing a single SMN1 copy , 2007, Neuromuscular Disorders.
[12] Gunadi,et al. A novel mutation at the N-terminal of SMN Tudor domain inhibits its interaction with target proteins , 2007, Journal of Neurology.
[13] J. Manley,et al. An intronic element contributes to splicing repression in spinal muscular atrophy , 2007, Proceedings of the National Academy of Sciences.
[14] B. Wirth,et al. Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy , 2005, Human mutation.
[15] P. Bénit,et al. Molecular analysis of SMA patients without homozygous SMN1 deletions using a new strategy for identification of SMN1 subtle mutations , 2004, Human mutation.
[16] M. Barceló,et al. Detection of novel mutations in the SMN Tudor domain in type I SMA patients , 2004, Neurology.
[17] J. Manley,et al. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy , 2003, Nature Genetics.
[18] K. Zerres,et al. Determination of SMN1 and SMN2 copy number using TaqMan™ technology , 2003, Human mutation.
[19] S. Ogino,et al. Inverse correlation between SMN1 and SMN2 copy numbers: evidence for gene conversion from SMN2 to SMN1 , 2003, European Journal of Human Genetics.
[20] R. Sutomo,et al. Correlation between SMN2 copy number and clinical phenotype of spinal muscular atrophy: three SMN2 copies fail to rescue some patients from the disease severity , 2002, Journal of Neurology.
[21] A. Munnich,et al. A novel association of the SMN protein with two major non-ribosomal nucleolar proteins and its implication in spinal muscular atrophy. , 2002, Human molecular genetics.
[22] C. Hernández-Chico,et al. Genetic study of SMA patients without homozygous SMN1 deletions: identification of compound heterozygotes and characterisation of novel intragenic SMN1 mutations , 2002, Human Genetics.
[23] T. Wienker,et al. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. , 2002, American journal of human genetics.
[24] Chadwick M. Hales,et al. Direct Interaction of the Spinal Muscular Atrophy Disease Protein SMN with the Small Nucleolar RNA-associated Protein Fibrillarin* , 2001, The Journal of Biological Chemistry.
[25] Y. Jong,et al. Molecular analysis of SMN, NAIP and P44 genes of SMA patients and their families , 2001, Journal of the Neurological Sciences.
[26] K. Davies,et al. Characterisation of novel point mutations in the survival motor neuron gene SMN, in three patients with SMA , 2001, Human Genetics.
[27] G. Neri,et al. Premature termination mutations in exon 3 of the SMN1 gene are associated with exon skipping and a relatively mild SMA phenotype , 2001, European Journal of Human Genetics.
[28] G. Matthijs,et al. Genotype determination at the survival motor neuron locus in a normal population and SMA carriers using competitive PCR and primer extension , 2000, Human mutation.
[29] U. Monani,et al. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy. , 2000, Human molecular genetics.
[30] R. Lührmann,et al. Essential role for the tudor domain of SMN in spliceosomal U snRNP assembly: implications for spinal muscular atrophy. , 1999, Human molecular genetics.
[31] J. McPherson,et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. , 1999, Human molecular genetics.
[32] C. Ponting,et al. Analysis of mutations in the tudor domain of the survival motor neuron protein SMN , 1999, European Journal of Human Genetics.
[33] D. Parsons,et al. Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number. , 1998, American journal of human genetics.
[34] J. Melki,et al. Spinal muscular atrophy. , 1997, Current opinion in neurology.
[35] B. Wirth,et al. Missense mutations in exon 6 of the survival motor neuron gene in patients with spinal muscular atrophy (SMA). , 1997, Human molecular genetics.
[36] A. Munnich,et al. Structure and organization of the human survival motor neurone (SMN) gene. , 1996, Genomics.
[37] H. Scheffer,et al. Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy. , 1995, American journal of human genetics.
[38] J. Osinga,et al. PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy , 1995, The Lancet.
[39] J. Weissenbach,et al. Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.
[40] R. Touraine,et al. A rare SMN2 variant in a previously unrecognized composite splicing regulatory element induces exon 7 inclusion and reduces the clinical severity of spinal muscular atrophy , 2010, Human mutation.
[41] 原田 陽介. Correlation between SMN2 copy number and clinical phenotype of spinal muscular atrophy : three SMN2 copies fail to rescue some patients from the disease severity , 2005 .
[42] B. Wirth,et al. Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2 , 2002, Genetics in Medicine.